- Cedara to demonstrate its new C4 integration platform, a system that
allows OEM companies to tightly integrate clinical applications into their
existing solutions
- Through a single integration effort, C4 allows companies to support
diverse functionality for their customers including breast imaging, PET/CT,
orthopaedic planning, virtual colonoscopy, calcium scoring, oncology
therapy response, lung nodule analysis and more
- Solutions contribute to Cedara's range of products and services for rapid
application development in the healthcare space
TORONTO, Nov. 15 /PRNewswire-FirstCall/ -- Cedara Software, a Merge
Healthcare company (Nasdaq: MRGE; TSX: MRG) and a leading independent
developer of medical software technologies for the global healthcare
market, today announced plans to introduce new solutions for integrated
imaging workflow at the 2006 RSNA conference held November 26 - 30 in
Chicago, Illinois.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030430/MRGELOGO )
With the increasing prevalence of multiple PACS installations, clinical
applications and information systems used at a single healthcare
institution, the need for integration has never been greater. At RSNA 2006,
Cedara Software will showcase a variety of new technologies for OEM/VARs
designed to further unite image and information management in the
healthcare industry. In this rapidly changing landscape, Cedara's solutions
provide a fast, efficient and cost effective means to introduce new
technology to the marketplace.
At the forefront of Cedara's approach to integrated image and
information management is a new development platform, named C4 (Cedara
Clinical Control Center(TM)*). C4 is an innovative platform that allows
clinical applications and plug-ins to be tightly integrated into a single
workstation, sharing system resources. Operating through a single patient
study list, each clinical application can be launched manually or
automatically based on user preferences. While C4 can be used to quickly
integrate clinical applications into any information system, it will be
demonstrated at RSNA with Cedara's web enabled PACS system Cedara
I-Reach(TM), a diagnostic information system Cedara aXigate(TM), and in a
standalone capacity.
Clinical needs addressed via C4 currently include breast imaging,
PET/CT imaging, orthopaedic planning, virtual colonoscopy, calcium scoring,
oncology therapy response and lung nodule analysis. These capabilities are
supported by Cedara's clinical applications Cedara I-ReadMammo(TM), Cedara
PET/CT Workstation, Cedara OrthoWorks ProPlanner(TM)*, Cedara OrthoWorks
Spine Analyzer(TM), Cedara IlumiView(TM), Cedara CalScore(R), Cedara I-
Response(TM)*, Cedara PrimeLung(TM) and more. It is anticipated that
additional clinical applications will be available through C4 in the
future.
"C4 promises to set a new standard for integration and ease-of-use for
clinical applications in the healthcare industry," said Ken Rardin,
President of Cedara Software and CEO of Merge Healthcare. "For many
vendors, engineering costs and time-to-market have a significant impact on
their decision to develop applications that address specialists' needs;
using C4, these applications can be quickly added to existing PACS, RIS and
EMR solutions to support a more a comprehensive workflow in a fast and cost
effective manner."
To support rapid application development, Cedara will also demonstrate
a variety of solutions that have been built using the Cedara OpenEyes
development platform. Cedara OpenEyes sets a new industry standard for
rapid application development. Including all of the essential imaging
functionality for high-level viewing solutions such as volume rendering in
3D, OpenEyes' programming model represents a paradigm shift from previous
technologies, completely insulating clients from the complexities of deep
code development by providing a single uniform set of controls and
development interfaces. OpenEyes packages connectivity, visualization and
printing services in a flexible and transparent architecture that can be
deployed across a wide spectrum of application environments -- from small
"one-off" projects to complex web solution services. Cedara OpenEyes is
available to OEM organizations interested in accelerating their time to
market.
Cedara's offerings at RSNA will include a wide range of solutions for
including image enhancement for modality manufacturers, segmentation
solutions, deformable registration, tumour contouring, connectivity
products, image stitching, CAD, RIS/PACS, automatic measurements, 3D, tools
for integrated diagnostic information and more.
"Today's need for service capabilities that stretch across the entire
healthcare enterprise, put significant pressure on companies that have
traditionally played in niche markets," continued Rardin. "Cedara is in a
very unique position to help medical technology companies broaden their
market reach and accelerate their time-to-market. From our development
platforms and toolkits to complete applications that can be private labeled
and seamlessly operate within another host, Cedara has a large range of
products for the OEM community. Cedara's long history and experience with
custom engineering services also provide a cost effective means to ramp up
product development and provide additional support for internal resources.
Any company interested in seeing Cedara's next generation solutions should
visit our booth at RSNA."
Cedara Software will be located at booth 4716, Hall A (South Hall) at
McCormick Place in Chicago, Illinois during the annual meeting of the
Radiology Society of North America (RSNA) held November 26 - 30, 2006.
*Some of the capabilities mentioned above represent works-in-progress.
Cedara Software is a Merge Healthcare company focused on the
development of custom engineered software applications and development
tools for the medical imaging OEM and International markets. Cedara
software is deployed in hospitals and clinics worldwide and is licensed by
many of the world's leading medical device and healthcare information
technology companies. Cedara technologies and expertise span all the major
digital imaging modalities including computed tomography (CT), magnetic
resonance imaging (MRI), digital X-ray, mammography, ultrasound,
echo-cardiology, angiography, nuclear medicine, positron emission
tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used
in all aspects of clinical imaging workflow including the capture of a
patient's digital image; the archiving, communication and manipulation of
digital images; sophisticated clinical applications to analyze digital
images; and the use of imaging in minimally-invasive surgery. For
additional information, visit our website at http://www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of
medical imaging and information management software and services. With over
twenty years of leadership in the medical imaging and healthcare
information technology markets, Merge Healthcare provides innovative
solutions for both OEM and the end-user healthcare markets. We custom
engineer clinical and imaging applications and development tools that are
on the forefront of medicine and its use of medical imaging for OEM and
international customers. We develop innovative medical imaging software
solutions that support end-to- end business and clinical workflow for
radiology department and specialty practices, imaging centers and
hospitals. Our innovative software solutions use leading-edge imaging
software technologies that accelerate market delivery for our OEM
customers, while our end-user solutions improve our customers' productivity
and enhance the quality of patient care they provide. For additional
information, visit our website at http://www.merge.com.
All trademarks appearing in this release are the property of Cedara
Software Corp. and/or Merge Healthcare.
Except for the historical information herein, the matters discussed in
this news release include forward looking statements that may involve a
number of risks and uncertainties. When used in this press release, the
words "will," "believes," "intends," "anticipates," "expects" and similar
expressions are intended to identify forward-looking statements. Actual
results could differ materially from those expressed in, or implied by, the
forward-looking statements based on a number of factors, including, but not
limited to, the uncertainty created by, the adverse impact on relationships
with customers, potential customers, suppliers and investors potentially
resulting from, and other risks associated with, the changes in the
Company's senior management; costs, risks and effects of the investigation
by the Audit Committee of the Board of Directors; the impact of the
restatement of financial statements of the Company and other actions that
may be taken or required as a result of such restatement; risks associated
with the Company's possible delisting from the Nasdaq Global Market; costs,
risks and effects of legal proceedings and investigations, including the
informal, non-public inquiry being conducted by the Securities and Exchange
Commission and class action, derivative, and other lawsuits; risks in
product and technology development, market acceptance of new products and
continuing product demand, the impact of competitive products and pricing,
ability to integrate acquisitions, changing economic conditions, credit and
payment risks associated with end-user sales, dependence on major
customers, dependence on key personnel, and other risk factors detailed in
the Company's filings with the Securities and Exchange Commission. Except
as expressly required by the federal securities laws, the Company
undertakes no obligation to update such factors or to publicly announce the
results of any of the forward-looking statements contained herein to
reflect future events, developments, or changed circumstances, or for any
other reason.
SOURCE Cedara Software
 back to top
Related links:
http://www.cedara.com
http://www.merge.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20030430/MRGELOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Jacques Cornet, VP of Strategic Marketing and
Business Development of Cedara Software Corp., +1-905-672-2100 x
2564, jacques.cornet@cedara.com; or Media: Beth Frost-Johnson,
Sr. VP of Marketing of Merge Healthcare, +1-414-977-4254,
bethfj@merge.com
|
